Publication | Open Access
BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer
16
Citations
17
References
2022
Year
We speculate that BUB1, BUB1B, and BUB3 may be therapeutic targets for BrCa patients and also provide new therapeutic strategies for BrCa treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1